Safety, tolerability, and efficacy estimate of evoked gamma oscillation in mild to moderate Alzheimer ’s disease

ConclusionOur results demonstrate that 1-h daily treatment with Cognito’s Evoked Gamma Therapy System (CogTx-001) was safe and well-tolerated and demonstrated potential clinical benefits in mild to moderate AD.Clinical Trial Registration:www.ClinicalTrials.gov, identifier: NCT03556280.
Source: Frontiers in Neurology - Category: Neurology Source Type: research